AcuCort expected to gain patent protection in the US
AcuCort AB (AktieTorget: ACUC) today announces that the US Patent and Trademark Office (USPTO) has issued a ”Notice of Allowance” for the company’s patent application for medical formulations containing glucocorticoids for self-treatment in acute situations, ”Acute Glucocorticoid Therapy”.”Notice of Allowance” is a part of the approval process where UPSTO confirms that the application process is completed and the issuance of the patent is now starting. The patent is expected to be issued during the second quarter 2018. The US patent application no. 11/587,512 describes medical self-